Sort   by:  
 Page size 
ProteomicsQuantitative proteomics uncovers the regulation of energy metabolism by Shexiang Baoxin Pill in myocardial infarction model rats
Ethnopharmacological relevance: Shexiang Baoxin Pill (SBP) is a traditional formulation of a Chinese patent medicine, which has been commonly used for the treatment of cardiovascular disease (CVD) in China since the 1980s. Previous clinical studies have shown that SBP is safe and effective in patien...
ORGANISM(S): Rattus norvegicus (Rat) 
2020-12-14 | PXD019296 | Pride
Shexiang baoxin pill  cardiovascular disease  lc-ms/ms  quantitative proteomics  energy metabolism 
UnknownEffects of Shexiang Baoxin Pill for Coronary Microvascular Function: A Systematic Review and Meta-Analysis.
Not available
S-EPMC8592925 | biostudies-literature
TranscriptomicsSingle-nucleus Ribonucleic Acid-sequencing and Spatial Transcriptomics Reveal the Cardioprotection of Shexiang Baoxin Pill (MUSKARDIA) in Mice with Myocardial Ischemia-Reperfusion Injury
The Shexiang Baoxin Pill (MUSKARDIA) has been extensively used to treat cardiovascular diseases in China for four decades, and its clinical efficacy has been widely approved. However, the mechanism by which this is achieved remains largely unexplored. Research attempting to understand the underlying...
ORGANISM(S): Mus musculus 
2023-04-26 | GSE227238 | GEO
TranscriptomicsSingle-nucleus Ribonucleic Acid-sequencing and Spatial Transcriptomics Reveal the Cardioprotection of Shexiang Baoxin Pill (MUSKARDIA) in Mice with Myocardial Ischemia-Reperfusion Injury
The Shexiang Baoxin Pill (MUSKARDIA) has been extensively used to treat cardiovascular diseases in China for four decades, and its clinical efficacy has been widely approved. However, the mechanism by which this is achieved remains largely unexplored. Research attempting to understand the underlying...
ORGANISM(S): Mus musculus 
2023-03-12 | GSE227088 | GEO
UnknownEffects of Shexiang Baoxin pill combined with exercise rehabilitation training on long-term prognosis of CTO-PCI patients: study protocol for randomized controlled trial.
Not available
S-EPMC12588978 | biostudies-literature
GenomicsSingle-nucleus Ribonucleic Acid-sequencing and Spatial Transcriptomics Reveal the Cardioprotection of Shexiang Baoxin Pill (MUSKARDIA) in Mice with Myocardial Ischemia-Reperfusion Injury
Single-nucleus Ribonucleic Acid-sequencing and Spatial Transcriptomics Reveal the Cardioprotection of Shexiang Baoxin Pill (MUSKARDIA) in Mice with Myocardial Ischemia-Reperfusion Injury
PRJNA943209 | ENA
GenomicsSingle-nucleus Ribonucleic Acid-sequencing and Spatial Transcriptomics Reveal the Cardioprotection of Shexiang Baoxin Pill (MUSKARDIA) in Mice with Myocardial Ischemia-Reperfusion Injury
Single-nucleus Ribonucleic Acid-sequencing and Spatial Transcriptomics Reveal the Cardioprotection of Shexiang Baoxin Pill (MUSKARDIA) in Mice with Myocardial Ischemia-Reperfusion Injury
PRJNA944210 | ENA
UnknownShexiang Baoxin Pill for Acute Myocardial Infarction: Clinical Evidence and Molecular Mechanism of Antioxidative Stress.
Not available
S-EPMC8652282 | biostudies-literature
UnknownMeta-analysis and trial sequential analysis of shexiang baoxin pill for coronary slow flow.
Not available
S-EPMC9441803 | biostudies-literature
UnknownA network-based method for mechanistic investigation of Shexiang Baoxin Pill's treatment of cardiovascular diseases.
Not available
S-EPMC5341564 | biostudies-literature
Sort   by:  
 Page size